Shailly Gupta
@shaillygupta.bsky.social
Senior Communications Advisor, MSF Access Campaign. Avid follower of intellectual property and pro-access news. Believer of #ClaimingRightsNotCharity. Opinions are mine and doesn't represent my employer.
watch here if you missed the session www.youtube.com/live/XBqQUT1...
Fighting TB in Kids: A Discussion with Doctors without Borders
YouTube video by vlogbrothers
www.youtube.com
November 13, 2025 at 3:03 PM
watch here if you missed the session www.youtube.com/live/XBqQUT1...
Read our response to recently released Global TB Report 2025 as well: msfaccess.org/msf-responds...
MSF responds to WHO’s annual Global TB Report: Governments and donors must close the deadly gap in diagnosing and treating TB in children
Deadly gap in diagnosing and treating TB in children persists as per Global TB report 2025
msfaccess.org
November 13, 2025 at 11:52 AM
Read our response to recently released Global TB Report 2025 as well: msfaccess.org/msf-responds...
Denis from ITPC says that there are definitely access issues on the ground in Europe concerning bedaquiline by Johnson & Johnson
October 14, 2025 at 2:16 PM
Denis from ITPC says that there are definitely access issues on the ground in Europe concerning bedaquiline by Johnson & Johnson
Big Pharma never stops surprising us!
October 14, 2025 at 2:12 PM
Big Pharma never stops surprising us!
Price in Spain of 6 months BPaL regimen is as high as €58,000 per treatment course while the same drug regimen costs around €275 in low and middle income countries
October 14, 2025 at 1:44 PM
Price in Spain of 6 months BPaL regimen is as high as €58,000 per treatment course while the same drug regimen costs around €275 in low and middle income countries
Spain is far way from goals set for reducing TB in Europe as per Jaime
October 14, 2025 at 1:40 PM
Spain is far way from goals set for reducing TB in Europe as per Jaime